Siga Technologies (SIGA) Other Operating Expenses (2010 - 2025)
Siga Technologies' (SIGA) quarterly Other Operating Expenses came in at $1.0 million in Q3 2025, down 38.16% on a YoY basis from $1.6 million in Q3 2024, and down 96.08% quarter-over-quarter from $25.6 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Other Operating Expenses (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Other Operating Expenses for 16 consecutive years, with $1.0 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Other Operating Expenses fell 38.16% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2025 stood at $40.8 million (up 27.8% YoY), and the FY2024 full-year result was $31.3 million, up 75.53% from the prior year.
- Other Operating Expenses fell to $1.0 million in Q3 2025 per SIGA's latest filing, from $25.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $25.6 million in Q2 2025 and bottomed at $83276.0 in Q3 2021.
- Historically, Other Operating Expenses has averaged $5.4 million across 5 years, with a median of $1.2 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Other Operating Expenses tumbled 98.54% in 2021, then soared 4642.03% in 2022.
- Over 5 years, Other Operating Expenses stood at $15.3 million in 2021, then tumbled by 94.23% to $881375.0 in 2022, then surged by 1579.64% to $14.8 million in 2023, then retreated by 4.54% to $14.1 million in 2024, then slumped by 92.91% to $1.0 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $1.0 million, $25.6 million, and $157738.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 25.55 Mn |
| Mar 31, 2025 | 157,738.00 |
| Dec 31, 2024 | 14.13 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 12.31 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 896,537.00 |
| Jun 30, 2023 | 974,420.00 |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 881,375.00 |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 882,096.00 |
| Mar 31, 2022 | 4.72 Mn |
| Dec 31, 2021 | 15.27 Mn |
| Sep 30, 2021 | 83,276.00 |
| Jun 30, 2021 | 995,990.00 |
| Mar 31, 2021 | 444,182.00 |
| Dec 31, 2020 | 3.81 Mn |